Research

Cellular

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately one-third of the population.

Health practitioners should be aware of the high prevalence of MASLD in their patient populations.

StrongSupportsmedium confidence
MASLD, previously known as nonalcoholic fatty liver disease (NAFLD), is a fast-growing global medical concern, affecting approximately one-third of the population, with numbers rising.
Anoushka Shenoy et al. · Metabolism and Target Organ Damage · 2025

Why this rating

The claim is based on a review of current evidence.

Source

Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease

Anoushka Shenoy et al. · Metabolism and Target Organ Damage · 2025

DOI 10.20517/mtod.2025.73

reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →